Scarica l'app Stockscreener
0.2157
2.23%
0.0047
Dopo l'orario di chiusura:
.22
0.0043
+1.99%
Aptevo Therapeutics Inc Borsa (APVO) Ultime notizie
Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated at StockNews.com - Defense World
Armistice Capital, LLC's Strategic Acquisition of Aptevo Therape - GuruFocus.com
Alligator Bioscience reports positive results for APV-527 in Phase 1 study - Marketscreener.com
Alligator Bioscience announces positive results for APV-527 - Marketscreener.com
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial - AccessWire
Aptevo's Cancer Drug Shows Promise: 56% of Patients Achieve Disease Stability in Phase 1 | APVO Stock News - StockTitan
Hudson Bay Capital Management LP's Strategic Acquisition in Aptevo Therapeutics Inc - GuruFocus.com
Aptevo Therapeutics Inc (APVO) Quarterly 10-Q Report - Quartz
Aptevo Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update - AccessWire
Aptevo Therapeutics (NASDAQ:APVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Alligator Bioscience to present positive data for mitazalimab at SITC - Marketscreener.com
Aptevo Therapeutics Inc (NASDAQ: APVO) Has Great Upside Potential - Stocks Register
Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com - Defense World
Alligator Bioscience presents positive interim data from Phase 1 study - Marketscreener.com
Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024 - AccessWire
Aptevo and Alligator Bioscience to present Phase 1 trial data at SITC - Investing.com UK
Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Update - Defense World
Aptevo Therapeutics secures shareholder nod for key proposals By Investing.com - Investing.com South Africa
Aptevo Therapeutics secures shareholder nod for key proposals - Investing.com India
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga
There is no doubt that Aptevo Therapeutics Inc (APVO) ticks all the boxes. - SETE News
Aptevo Therapeutics Inc (NASDAQ: APVO) – An Analysis Is What You Need - Stocks Register
Stock Market Recap: Aptevo Therapeutics Inc (APVO) Concludes at 0.15, a -2.87 Surge/Decline - The Dwinnex
A stock that deserves closer examination: Aptevo Therapeutics Inc (APVO) - US Post News
APVO stock plunges to 52-week low of $0.14 amid market challenges - Investing.com Australia
APVO stock plunges to 52-week low of $0.14 amid market challenges By Investing.com - Investing.com South Africa
You might want to take a look at Aptevo Therapeutics Inc (APVO) now - SETE News
APVO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Gaining Ground: Aptevo Therapeutics Inc (APVO) Closes Lower at 0.16, Down -2.60 - The Dwinnex
Aptevo Therapeutics Inc (APVO) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Aptevo Therapeutics (NASDAQ:APVO) Research Coverage Started at StockNews.com - Defense World
Research Analysts’ Updated EPS Estimates for October 6th (APVO, CNP, FDX, FLNT, FRD, GALT, HOPE, KBR, LSXMK, NVGS) - Defense World
Aptevo Therapeutics Inc (APVO)’s stock decline to 0.16 per share - US Post News
APVO Stock Update: Aptevo Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
Financial Metrics Check: Aptevo Therapeutics Inc (APVO)’s Ratios for Trailing Twelve Months - The Dwinnex
Certain Restricted Stock Units of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 30-SEP-2024. - Marketscreener.com
Aptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News Summary - Benzinga
Aptevo Therapeutics (NASDAQ:APVO) Now Covered by StockNews.com - Defense World
Aptevo Therapeutics Inc Inc. (APVO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Down 78.8% in September - Defense World
Short Interest in Advantest Co. (OTCMKTS:ATEYY) Declines By 85.7% - MarketBeat
Applied Therapeutics (NASDAQ:APLT) Stock Price Up 5.2% - Defense World
Astria Therapeutics (NASDAQ:ATXS) Shares Gap Down to $12.50 - MarketBeat
DRW Securities LLC Invests $117,000 in Patterson-UTI Energy, Inc. (NASDAQ:PTEN) - Defense World
Gabelli Funds LLC Raises Stake in Aptiv PLC (NYSE:APTV) - Defense World
Aptevo Therapeutics Inc. (NASDAQ:APVO) to Post Q3 2024 Earnings of ($0.57) Per Share, Roth Capital Forecasts - Defense World
Aptiv PLC stock rises Tuesday, outperforms market - MarketWatch
Logos Global Management LP Sells 750,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Patterson-UTI Energy (NASDAQ:PTEN) Shares Down 3.5% - Defense World
PTEN’s Q2 earnings estimates: What investors need to know - US Post News
PTEN’s Market Whiplash: -22.96% YTD Decline, -10.63% Plunge in 30 Days - The InvestChronicle
Aptar's N-Sorb accepted into FDA Emerging Technology Program - Investing.com India
Did Aptevo Therapeutics Inc (APVO) perform well in the last session? - US Post News
Aptiv PLC (NYSE:APTV) Shares Sold by Summit Trail Advisors LLC - Defense World
Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by Logos Global Management LP - MarketBeat
Benjamin F. Edwards & Company Inc. Grows Position in Aptiv PLC (NYSE:APTV) - Defense World
New RNA specialist launches in Milan with $1.6 million - The Pharma Letter
Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors - Business Wire
Roth/MKM cuts Aptevo Therapeutics stock target, keeps Buy on clinical trial - Investing.com Canada
Recent Insider Activity Suggests Potential Gains for Aptiv PLC (APTV) - Knox Daily
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):